Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Lotus Pharmaceuticals adds five new prescription drugs to its products

Lotus Pharmaceuticals, Inc., a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported that it had added five new prescription drugs to its products delivered through its national sales channels.

3 Mar 2010

Novo Nordisk awarded contract by VA as primary source provider of insulin

Novo Nordisk, a global healthcare company and leader in diabetes care, announced it has been awarded a contract by the U.S. Department of Veterans Affairs as the primary source provider of insulin. The one year contract began on March 1, 2010 and the VA has the option to renew the contract annually for up to an additional four years.

From Novo Nordisk 3 Mar 2010

Not getting enough sleep can cause fat to accumulate around organs, say researchers

Not getting enough sleep does more damage than just leaving you with puffy eyes. It can cause fat to accumulate around your organs - more dangerous, researchers say, than those pesky love handles and jiggly thighs.

2 Mar 2010

Daily consumption of chlorella can help maintain healthy body

Americans' dietary habits have been scrutinized for being dependent on processed, refined and incomplete foods. This has left many Americans to reassess the foods they eat and essentially reconstruct their personal food pyramids.

2 Mar 2010

Future work may uncover links between insulin use and cancer risk, say researchers

The benefits of using insulin to treat diabetes far outweigh the risks, but a review just published online by IJCP, the International Journal of Clinical Practice, suggests that commonly used diabetes therapies may differ from each other when it comes to their influence on cancer risk.

2 Mar 2010

Praxis to provide patient recruitment services for international type 2 diabetes study

Praxis, a company specializing in centralized patient recruitment for clinical research studies, will provide patient recruitment services to a top 20 pharmaceutical company for an international study on type 2 diabetes. The study explores an investigational drug’s effectiveness for maintaining glycemic control for individuals newly diagnosed with type 2 diabetes.

2 Mar 2010

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Isis Pharmaceuticals, Inc. today announced its 2009 financial results and reviewed the highlights of the year. Isis achieved its 2009 financial guidance with pro forma net income of $166.9 million and a pro forma net operating loss (NOL) of $14.2 million compared with its guidance for the year of pro forma net income of more than $145 million and a pro forma NOL in the low to mid $20 million range. Isis also achieved its cash guidance by ending 2009 with $574.3 million of cash, cash equivalents and short-term investments significantly in excess of the $550 million projected.

1 Mar 2010

FDA accepts for filing VIVUS' Qnexa NDA

VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company's new drug application (NDA) for its investigational drug, Qnexa®, for the treatment of obesity. The target date for the FDA to complete its review of the Qnexa NDA is October 28, 2010.

1 Mar 2010

Government has yet to confirm funding for ADI

With the sunset date for the Aboriginal Diabetes Initiative (ADI) rapidly approaching, the government has yet to confirm whether or not funding will continue after March 31st.

1 Mar 2010

Using genetic engineering techniques in pigs, scientists create new model of diabetes

The incidence of diabetes is rising worldwide. Using genetic engineering techniques in pigs, scientists at Ludwig-Maximilians-Universität in Munich have created a new model of this metabolic disorder, which recapitulates many features of the disease, and promises to contribute significantly to improvements in diagnosis and therapy.

1 Mar 2010

Inadequate sleep may lead to increase in belly fat

A study in the March 1 issue of the journal SLEEP shows that African-American and Hispanic young adults with short or long sleep durations had greater increases in belly fat over a five-year period compared with those who reported sleeping six to seven hours a night.

1 Mar 2010

Study associates frequent napping with elevated prevalence of type 2 diabetes in older Chinese population

A study in the March 1 issue of the journal Sleep shows that frequent napping is associated with an elevated prevalence of type 2 diabetes and impaired fasting glucose in an older Chinese population.

1 Mar 2010

Precise immune disturbances leading to Coeliac disease: More insight

New research has identified four aspects of immune system disturbance which lead to the development of coeliac disease. Nearly 40 different inherited risk factors which predispose to the disease have now been identified. These latest findings could speed the way towards improved diagnostics and treatments for the autoimmune complaint that affects 1 in 100 of the population, and lead to insights into related conditions such as type 1 diabetes.

28 Feb 2010

University of Michigan Health System opens new facility for eye care, diabetes research

On March 1, the first eye patients will enter an innovative new $132 million facility that expands the University of Michigan Health System's capacity for eye care, research and education, and unites diabetes researchers as they work to accelerate the search for a cure and prevention of diabetes.

27 Feb 2010

Arena Pharmaceuticals' lorcaserin NDA: FDA assigns PDUFA date

Arena Pharmaceuticals, Inc. announced today that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of October 22, 2010, for the review of the lorcaserin New Drug Application (NDA). The acceptance of the lorcaserin NDA filing confirms that the application is sufficiently complete to permit a substantive review, and the PDUFA date is the goal date for the FDA to complete its review of the NDA.

26 Feb 2010

Community-wide wellness initiative to deliver preventive health care services to northwest Arkansas

U.S. Preventive Medicine® and Washington Regional Medical Center, together with Arkansas Occupational Health Clinic and Kids for Health, today introduced an initiative to deliver preventive health care services to northwest Arkansas. This community-wide wellness initiative aims to save lives and money by keeping Arkansans healthy and treating chronic illnesses before they progress.

26 Feb 2010

Over 600 programs for Aboriginal Canadians with diabetes at risk of being shut, renewed federal funding needed

The federal government must renew funding for the Aboriginal Diabetes Initiative (ADI) in next week's budget or more than 600 programs for Aboriginal Canadians living with diabetes are at risk of being shut down, according to the Canadian Diabetes Association and the National Aboriginal Diabetes Association (NADA).

26 Feb 2010

FDA sets new PDUFA action date for exenatide once weekly NDA

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has set a new Prescription Drug User Fee Act (PDUFA) action date of March 12 for its review of the exenatide once weekly new drug application (NDA).

25 Feb 2010

Study examines how individuals utilize benefits and services under Medicare program

Findings released today and detailed in the analysis Low Consumption and Higher Medicare Cost: Consumption Clusters in a Medicare Fee-for-Service Population, examine how individuals utilize benefits and services under the Medicare program.

25 Feb 2010

A surgical cure for diabetic and obese patients

Dr. Francesco Rubino, chief of gastrointestinal metabolic surgery at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, is now enrolling overweight and mildly obese patients -- those with a body mass index (BMI) of 28 to 35 -- in a study of gastric bypass surgery aimed at reversing Type 2 diabetes.

25 Feb 2010

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Lotus Pharmaceuticals adds five new prescription drugs to its products

Novo Nordisk awarded contract by VA as primary source provider of insulin

Not getting enough sleep can cause fat to accumulate around organs, say researchers

Daily consumption of chlorella can help maintain healthy body

Future work may uncover links between insulin use and cancer risk, say researchers

Praxis to provide patient recruitment services for international type 2 diabetes study

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

FDA accepts for filing VIVUS' Qnexa NDA

Government has yet to confirm funding for ADI

Using genetic engineering techniques in pigs, scientists create new model of diabetes

Inadequate sleep may lead to increase in belly fat

Study associates frequent napping with elevated prevalence of type 2 diabetes in older Chinese population

Precise immune disturbances leading to Coeliac disease: More insight

University of Michigan Health System opens new facility for eye care, diabetes research

Arena Pharmaceuticals' lorcaserin NDA: FDA assigns PDUFA date

Community-wide wellness initiative to deliver preventive health care services to northwest Arkansas

Over 600 programs for Aboriginal Canadians with diabetes at risk of being shut, renewed federal funding needed

FDA sets new PDUFA action date for exenatide once weekly NDA

Study examines how individuals utilize benefits and services under Medicare program

A surgical cure for diabetic and obese patients

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in